Iniparib (BSI-201)

Iniparib (BSI-201)

  • $970.00
    Unit price per 
Shipping calculated at checkout.


Iniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3.

We Also Recommend

×
Welcome Newcomer